Breast Cancer Clinical Trial
Official title:
Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy
Percutaneous large core image-guided breast biopsy is a well established tool in diagnosing breast cancer, but the associated anxiety and pain can tax the coping mechanism of even well functioning individuals. Unabated stress during an invasive procedure not only interferes with smooth progression of the ongoing procedure, but can also have deleterious effects when patients need additional procedures and dread recurrent medical traumatization. The long-term objective of this research is to provide patients with a simple coping strategy at the vulnerable time of large core biopsy in the hope that this behavioral intervention will carry over to recovery and future medical procedures. In the largest prospective randomized study of its kind, the researchers showed that a self-hypnotic intervention during percutaneous, image-guided vascular and renal interventions resulted in less pain and anxiety, greater hemodynamic stability, and fewer procedure interruptions. The positive effects of the short initial hypnotic intervention, which was structured in the procedure room, became more pronounced the longer the procedure lasted and carried over into the immediate post-procedure recovery. The investigators therefore challenge the current paradigms that long-lasting effects require intensive presurgical preparation.
| Status | Completed |
| Enrollment | 240 |
| Est. completion date | March 2004 |
| Est. primary completion date | March 2004 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Patients presenting for large core breast biopsy in the Radiology Department at the Beth Israel Deaconess Medical Center Boston. Exclusion Criteria: Patients are excluded if : - They are unable to give informed consent, or pass screening for impaired mental function or psychosis. - They are unable to hear or understand English. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
| Country | Name | City | State |
|---|---|---|---|
| United States | Beth Israel Deaconess Medical Center | Boston | Massachusetts |
| Lead Sponsor | Collaborator |
|---|---|
| Beth Israel Deaconess Medical Center | United States Department of Defense |
United States,
Lang EV, Berbaum KS, Faintuch S, Hatsiopoulou O, Halsey N, Li X, Berbaum ML, Laser E, Baum J. Adjunctive self-hypnotic relaxation for outpatient medical procedures: a prospective randomized trial with women undergoing large core breast biopsy. Pain. 2006 — View Citation
Lang EV, Berbaum KS, Lutgendorf SK. Large-core breast biopsy: abnormal salivary cortisol profiles associated with uncertainty of diagnosis. Radiology. 2009 Mar;250(3):631-7. doi: 10.1148/radiol.2503081087. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety to 10=worst possible anxiety. Patients self-reported anxiety at the beginning (time 0), every 10 minutes, and at the end of their biopsy procedure on a 0-10 numeric verbal anxiety scale (0=no anxiety at all, 10=worst possible anxiety). Participants were followed for the duration of the biopsy procedure, an average of 43 min. | 0 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 10 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 20 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 30 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 40 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 50 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 60 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 70 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 80 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 90 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 100 min | No |
| Primary | Anxiety Ratings at Specified Time Point During the Procedure | Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety | 110 min | No |
| Primary | Time Trends of Anxiety Experience | Ordinal regression analysis looks at data as a series of possible splits of patient responses and assesses the odds of experiencing a value at or above as compared to the split; e.g. the probability of experiencing self-reported anxiety scores of 0 vs 1-10; 0-2 vs 3-10 ; 0-4 vs 5-10 etc with anxiety scores reported between 0=no anxiety and 10=worst possible anxiety. The summary analysis with logit slopes gives in the time trend estimate the cumulative probabilities of the response categories over the variable N=procedure time (min). Positive slopes indicate increasing scores above the split point over time, negative slopes indicate decreasing scores, and flat lines no significant change. In the proportional odds model, an encompassing slope - a probability function of linear trend - is generated that not only applies to the logit forms of the individual splits but to the logic forms of graphs that portray all other splits. The resultant slopes then facilitate comparison among groups. | 0-110 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 0 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 10 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 20 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 30 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 40 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 50 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 60 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 70 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 80 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 90 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 100 min | No |
| Primary | Pain Ratings at Specified Time Point During the Procedure | Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain | 110 min | No |
| Primary | Time Trends of Pain Experience | Ordinal regression analysis looks at data as a series of possible splits of patient responses and assesses the odds of experiencing a value at or above as compared to the split; e.g. the probability of experiencing self-reported pain scores of 0 vs 1-10; 0-2 vs 3-10 ; 0-4 vs 5-10 etc with pain scores reported between 0=no pain, and 10=worst possible pain. The summary analysis with logit slopes gives in the time trend estimate the cumulative probabilities of the response categories over the variable N=procedure time (min). Positive slopes indicate increasing scores above the split point over time, negative slopes indicate decreasing scores, and flat lines no significant change. In the proportional odds model, an encompassing slope - a probability function of linear trend - is generated that not only applies to the logit forms of the individual splits but to the logic forms of graphs that portray all other splits. The resultant slopes then facilitate comparison among groups. | 0-110 min | No |
| Secondary | Salivary Cortisol Secretion | Secretion of cortisol over time is customarily described in terms of a slope with the time of day of cortisol measurement as the x variable and the natural logarithm of the measured cortisol concentration as the y variable. Cortisol slope is expressed as the natural logarithm of cortisol (micrograms per deciliter) per hour, with 1g/dL corresponding to 27.8 nmol/L. In general, greater negative slopes (with steeper decreases from high morning values to low evening values) are considered better adapted and healthier than flatter (less negative) slopes. | Patients were followed for the 5 days following their breast biopsy | No |
| Secondary | Impact of Event Scale (IES-15) | The IES is a measure of subjective distress for any specific life event. This 15-item self-report instrument is used to assess experiences of intrusive thoughts (Intrusion subscale) and attempts to consciously avoid such experiences (Avoidance subscale) that are commonly associated with subjective distress about life situations. Answers are given in four ratings from not at all (score 0) to often (score 5), with a possible TOTAL overall range of scores from zero to 75. =26 indicates moderate to severe distress) of women who at the time of return for breast surgery after their initial biopsy |
Patients were followed for up to 3 weeks after their biopsy until the time of their surgery | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |